These findings collectively suggest that corilagin exerts protective effects against ALI by suppressing the MAPKs, AKT, and STAT3 signaling pathways, in line with its modulation of TNF-α and IL-6 levels. The gene discussed is TNF; the disease is acute respiratory distress syndrome.